Cannabis Valuation

Sending a feeler out to the WSO community to see if anyone has experience across Cannabis valuations in today's market. Did a quick search but appears most threads are 5+ years old and the industry is completely different now and changing rapidly. Would be great to hear from other monkeys involved in the industry.

I'm particularly interested in valuing retail dispensaries and what a single dispensary valuation would look like vs. multi-dispensary model. There are lots of unknowns across this industry and valuations are all over the place. Some questions below if anyone has any insight:

  • Discount rates: What is everyone using for appropriate discount rates? It's obviously a risky business at this point and the comp sets are limited (though growing every day). How are you discounting future CF and building in the risk of the industry never becoming federally legal, becoming federally legal, states opening up a huge supply of licenses that floods the markets with new entrants, etc? What does an appropriate discount rate truly look like?
  • Valuing a vertically integrated company vs. a purely retail-only operation. Better margins will be had with the former but eventually, cannabis will be so commoditized there may be little to no value in being vertically integrated unless required by the state its operating in.
  • # of licenses: What premium do you attribute to a business that is operating 20 retail operations with 20 licenses vs. a single retail operation with a single license? Also, those companies that hold the only license in a city vs a retail operation that owns 1 of 20 in a specific city, outside of # of customers, what effects are you seeing?
  • Multiples: Multiples are insane right now with many companies with negative EBITDA and being valued off of revenue. Looks like forward-looking multiples 2-3+ years come into reality when companies begin to generate EBITDA and the multiples come back to earth. How are you approaching this?

Seems like more and more boutique PE shops are strategically getting into the ancillary side of Cannabis and slowly moving into the plant touching operations. Would be great to start a conversation. Cheers.

 

My advice: keep unsystematic risks out of your discount rate

Most of the risks you list are not systematic risks and therefore I prefer not to correct for them in your beta nor overall discount rate. Adding a few percentage point to WACC is very arbitrary and almost impossible to interpret as you use it in a non-linear function.

Alternative

In my view most appropriate would be a discount rate derived from a mature adjacent industry (e.g. (food)retailing, leisure or pharma) and then make separate forecasts for the key business risks you describe. Assign a probability to each of them (that add up to 100%) to get to a valuation. This way you can handle sector specific trends that will have a different impact on every business.

 

Sed asperiores nemo ratione maiores et accusamus fugit. Animi distinctio reiciendis neque dolorem praesentium nemo est ipsum. Perferendis alias possimus est iusto pariatur nulla et pariatur. Corrupti ut eos ab explicabo qui voluptate corrupti.

Eos harum neque ut repudiandae optio perspiciatis adipisci. Molestiae veritatis eius non neque nobis. Vitae ut itaque error blanditiis fugiat sit necessitatibus.

Magni non eligendi ducimus cupiditate culpa est. Eligendi dolorem adipisci harum qui et. Repellendus ut eligendi officia. Quod sit doloribus ipsam quia. Animi aliquid beatae enim aut qui. Quia sequi porro nisi quae voluptas recusandae.

Career Advancement Opportunities

March 2024 Private Equity

  • The Riverside Company 99.5%
  • Warburg Pincus 99.0%
  • Blackstone Group 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

March 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

March 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

March 2024 Private Equity

  • Principal (9) $653
  • Director/MD (21) $586
  • Vice President (92) $362
  • 3rd+ Year Associate (89) $280
  • 2nd Year Associate (204) $268
  • 1st Year Associate (386) $229
  • 3rd+ Year Analyst (28) $157
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (313) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
kanon's picture
kanon
98.9
6
dosk17's picture
dosk17
98.9
7
GameTheory's picture
GameTheory
98.9
8
CompBanker's picture
CompBanker
98.9
9
DrApeman's picture
DrApeman
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”